Related Experiment Video
Updated: Aug 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
The ARF tumor suppressor: keeping Myc on a leash
Mark A Gregory1, Ying Qi, Stephen R Hann
1Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2175, USA.
Abstract:
The ARF tumor suppressor protein acts in a checkpoint that guards against unscheduled cellular proliferation in response to oncogenic signaling. Deregulated expression of c-Myc induces ARF expression and apoptosis through the ARF-Mdm2-p53 axis. Our recent study reveals a new direct role for ARF in controlling c-Myc's oncogenic activity that is independent of p53. ARF binds to and selectively impairs the transactivation ability of c-Myc while leaving its transrepression ability intact. Biologically, ARF prevents hyper-proliferation and transformation caused by c-Myc and enhances c-Myc-induced apoptosis independently of p53. These new findings may be especially relevant for therapeutic strategies targeting c-Myc-induced cancers.
Insights
The ARF tumor suppressor protein directly inhibits c-Myc
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- ARF (Alternative Reading Frame) is a tumor suppressor protein crucial for cell cycle checkpoints.
- ARF-Mdm2-p53 pathway regulates apoptosis in response to oncogenic stress like c-Myc.
- c-Myc is an oncogene frequently deregulated in various cancers.
Purpose of the Study:
- To investigate a novel, p53-independent role of ARF in regulating c-Myc's oncogenic functions.
- To elucidate the mechanism by which ARF directly controls c-Myc activity.
Main Methods:
- Biochemical assays to study the interaction between ARF and c-Myc.
- Functional assays assessing c-Myc's transactivation and transrepression abilities.
- Cellular proliferation and apoptosis assays in the presence of ARF and c-Myc.
Main Results:
- ARF directly binds to c-Myc, selectively inhibiting its transactivation function.
- ARF's inhibitory effect on c-Myc is independent of the p53 pathway.
- ARF suppresses c-Myc-driven cellular hyper-proliferation and transformation, and enhances apoptosis.
Conclusions:
- ARF possesses a direct, p53-independent mechanism to counteract c-Myc's oncogenic potential.
- These findings offer new insights into cancer development and potential therapeutic targets.
- Targeting the ARF-c-Myc interaction could be a viable strategy for treating c-Myc-driven cancers.
More Related Videos
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

